Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stran & Company (SWAG) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Stran & Company (SWAG) over the last 6 years, with Q3 2025 value amounting to $6.7 million.

  • Stran & Company's Cash & Equivalents fell 3327.02% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year decrease of 3327.02%. This contributed to the annual value of $9.4 million for FY2024, which is 1611.86% up from last year.
  • Latest data reveals that Stran & Company reported Cash & Equivalents of $6.7 million as of Q3 2025, which was down 3327.02% from $13.1 million recorded in Q2 2025.
  • In the past 5 years, Stran & Company's Cash & Equivalents ranged from a high of $40.0 million in Q1 2022 and a low of $797428.0 during Q3 2021
  • Moreover, its 5-year median value for Cash & Equivalents was $10.7 million (2023), whereas its average is $13.9 million.
  • As far as peak fluctuations go, Stran & Company's Cash & Equivalents surged by 487912.94% in 2021, and later crashed by 7333.82% in 2023.
  • Stran & Company's Cash & Equivalents (Quarter) stood at $32.2 million in 2021, then tumbled by 52.67% to $15.3 million in 2022, then crashed by 47.17% to $8.1 million in 2023, then rose by 16.12% to $9.4 million in 2024, then fell by 28.44% to $6.7 million in 2025.
  • Its Cash & Equivalents was $6.7 million in Q3 2025, compared to $13.1 million in Q2 2025 and $4.2 million in Q1 2025.